Dr. Peter Capucilli, MD

Dr. Capucilli practices at Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York.

Dr. Capucilli's NPI, 1801208590, was assigned on May 29, 2014. Dr. Capucilli graduated from University of Rochester School of Medicine and Dentistry in 2014. Dr. Capucilli holds New York license 303459.

Dr. Capucilli's primary practice is Alexander Park Campus - Diabetes and Endocrinology, at 224 Alexander St, Rochester, NY 14607 in Monroe County. The practice phone is (585) 922-8400.

Dr. Capucilli's primary practice is Alexander Park Campus - Diabetes and Endocrinology in Rochester, New York. Dr. Capucilli is also affiliated with Rochester General Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Capucilli to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Capucilli practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Capucilli's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Capucilli is licensed in New York.

CMS data shows 44 Medicare services from Dr. Capucilli across 2 procedure codes in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $3,137 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Capucilli in 2024. The largest group is 65 to 74, with 16 patients. 72% of them have high blood pressure, and 62% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Capucilli's median patient age at 27, with 55% women.

In 2024, Dr. Capucilli wrote 638 Medicare Part D claims for 137 patients. 56% of them were for generic drugs. CMS names the drug for 541 of them, across 18 drugs with 11 or more claims each, at $290,929 in total drug cost. In 2023, CMS named 323 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Capucilli for performance year 2024, reported through an alternative payment model (APM). Dr. Capucilli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Capucilli, published from 2018 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Allergens, Desensitization, Immunologic and Food Hypersensitivity. Dr. Capucilli has published most often in Ann Allergy Asthma Immunol. Dr. Capucilli's most frequent co-authors are Jonathan M. Spergel, MD, Allison Clare Ramsey, MD and Linh-An C. Tuong, MD.

CMS Open Payments shows 16 general payments to Dr. Capucilli from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 51% of the total. Sanofi and Genzyme US Companies paid the most, $811.

Dr. Capucilli graduated from University of Rochester School of Medicine and Dentistry in 2014.